
Acutus Medical AFIB
Quarterly report 2024-Q3
added 11-14-2024
Acutus Medical Accounts Payables 2011-2026 | AFIB
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Acutus Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.76 M | 2.47 M | 7.52 M | 8.27 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.27 M | 2.47 M | 5.25 M |
Quarterly Accounts Payables Acutus Medical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.71 M | 1.68 M | 3.16 M | 2.76 M | 4.75 M | 5.49 M | 5.57 M | 4.72 M | 4.64 M | 7.98 M | 4.78 M | 7.52 M | 6.42 M | 5.79 M | 6.11 M | 8.27 M | 8.27 M | 8.27 M | 8.27 M | 3.88 M | 3.88 M | 3.88 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.27 M | 1.68 M | 5.35 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
535 K | $ 2.2 | -0.45 % | $ 3.43 M | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
AdaptHealth Corp.
AHCO
|
352 M | $ 10.55 | 0.91 % | $ 1.43 B | ||
|
Alphatec Holdings
ATEC
|
40.9 M | $ 12.94 | -0.84 % | $ 1.94 B | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
Cognyte Software Ltd.
CGNT
|
25.2 M | $ 8.29 | -0.84 % | $ 595 M | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
ClearPoint Neuro
CLPT
|
1.26 M | $ 9.69 | -13.17 % | $ 274 M | ||
|
Butterfly Network
BFLY
|
4.25 M | $ 4.05 | -4.93 % | $ 857 M | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
1.14 B | $ 70.93 | -0.45 % | $ 105 B | ||
|
Cytosorbents Corporation
CTSO
|
3.34 M | $ 0.66 | -2.96 % | $ 35.9 M | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.96 | -2.28 % | $ 148 M | ||
|
CONMED Corporation
CNMD
|
93.6 M | $ 37.07 | -0.3 % | $ 1.15 B | ||
|
Establishment Labs Holdings
ESTA
|
43.1 M | $ 65.5 | 0.75 % | $ 1.94 B | ||
|
Cutera
CUTR
|
19.8 M | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
FONAR Corporation
FONR
|
1.55 M | $ 18.45 | -0.03 % | $ 121 M | ||
|
GBS
GBS
|
1.47 M | - | -0.57 % | $ 7.12 M | ||
|
Abbott Laboratories
ABT
|
4.24 B | $ 108.88 | -1.69 % | $ 190 B | ||
|
InMode Ltd.
INMD
|
17.9 M | $ 13.57 | -0.59 % | $ 877 M | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 9.46 | -2.87 % | $ 339 M | ||
|
IRIDEX Corporation
IRIX
|
4.5 M | $ 1.33 | - | $ 21.5 M | ||
|
Bio-Rad Laboratories
BIO
|
122 M | $ 269.22 | -0.06 % | $ 7.6 B | ||
|
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 16.83 | -2.21 % | $ 395 M | ||
|
Helius Medical Technologies
HSDT
|
531 K | $ 2.07 | -4.61 % | $ 1.26 M | ||
|
AxoGen
AXGN
|
2.89 M | $ 30.96 | -5.48 % | $ 1.43 B | ||
|
Align Technology
ALGN
|
109 M | $ 172.07 | -2.3 % | $ 12.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
82.5 M | $ 8.89 | -2.31 % | $ 685 M | ||
|
Bruker Corporation
BRKR
|
234 M | $ 34.23 | 1.45 % | $ 5.1 K | ||
|
Apyx Medical Corporation
APYX
|
3.06 M | $ 3.73 | -0.27 % | $ 153 M | ||
|
Second Sight Medical Products
EYES
|
817 K | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
34 M | $ 0.4 | 1.81 % | $ 41.1 M | ||
|
IRadimed Corporation
IRMD
|
1.82 M | $ 101.27 | -1.49 % | $ 1.29 B |